![]()
|
|
||||||||
J. Biol. Chem., Vol. 262, Issue 10, 4437-4440, Apr, 1987
E Appella, EA Robinson, SJ Ullrich, MP Stoppelli, A Corti, G Cassani and F Blasi
Previous studies have shown that the region of human urokinase-type
plasminogen activator (uPA) responsible for receptor binding resides in the
amino-terminal fragment (ATF, residues 1-135) (Stoppelli, M.P., Corti, A.,
Soffientini, A., Cassani, G., Blasi, F., and Assoian, R.K. (1985) Proc.
Natl. Acad. Sci. U.S. A. 82, 4939-4943). The area within ATF responsible
for specific receptor binding has now been identified by the ability of
different synthetic peptides corresponding to different regions of the
amino terminus of uPA to inhibit receptor binding of 125I-labeled ATF. A
peptide corresponding to human [Ala19]uPA-(12-32) resulted in 50%
inhibition of ATF binding at 100 nM. Peptides uPA-(18-32) and
[Ala13]uPA-(9-20) inhibit at 100 and 2000 microM, respectively. The human
peptide uPA-(1-14) and the mouse peptide [Ala20]uPA-(13-33) have no effect
on ATF receptor binding. This region of uPA is referred to as the growth
factor module since it shares partial amino acid sequence homology
(residues 14-33) to epidermal growth factor (EGF). Furthermore, this region
of EGF is responsible for binding of EGF to its receptor (Komoriya, A.
Hortsch, M., Meyers, C., Smith, M., Kanety, H., and Schlessinger, J. (1984)
Proc. Natl. Acad. Sci. U.S.A. 81, 1351-1355). However, EGF does not inhibit
ATF receptor binding. Comparison of the sequences responsible for receptor
binding of uPA and EGF indicate that the region of highest homology is
between residues 13-19 and 14-20 of human uPA and EGF, respectively. In
addition, there is a conservation of the spacings of four cysteines in this
module whereas there is no homology between residues 20-30 and 21-33 of uPA
and EGF. Thus, residues 20-30 of uPA apparently confer receptor binding
specificity, and residues 13-19 provide the proper conformation to the
adjacent binding region.
The receptor-binding sequence of urokinase. A biological function for the growth-factor module of proteases
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
V. Stepanova, T. Lebedeva, A. Kuo, S. Yarovoi, S. Tkachuk, S. Zaitsev, K. Bdeir, I. Dumler, M. S. Marks, Y. Parfyonova, et al. Nuclear translocation of urokinase-type plasminogen activator Blood, July 1, 2008; 112(1): 100 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hillig, L. H. Engelholm, S. Ingvarsen, D. H. Madsen, H. Gardsvoll, J. K. Larsen, M. Ploug, K. Dano, L. Kjoller, and N. Behrendt A Composite Role of Vitronectin and Urokinase in the Modulation of Cell Morphology upon Expression of the Urokinase Receptor J. Biol. Chem., May 30, 2008; 283(22): 15217 - 15223. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, Z.-H. Zhou, T. H. Bugge, and L. M. Wahl Urokinase-Type Plasminogen Activator Stimulation of Monocyte Matrix Metalloproteinase-1 Production Is Mediated by Plasmin-Dependent Signaling through Annexin A2 and Inhibited by Inactive Plasmin J. Immunol., September 1, 2007; 179(5): 3297 - 3304. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Franco, I. Vocca, M. V. Carriero, D. Alfano, L. Cito, I. Longanesi-Cattani, P. Grieco, L. Ossowski, and M. P. Stoppelli Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and {alpha}v{beta}5 integrin J. Cell Sci., August 15, 2006; 119(16): 3424 - 3434. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Alfano, I. Iaccarino, and M. P. Stoppelli Urokinase Signaling through Its Receptor Protects against Anoikis by Increasing BCL-xL Expression Levels J. Biol. Chem., June 30, 2006; 281(26): 17758 - 17767. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mazzieri, S. D'Alessio, R. K. Kenmoe, L. Ossowski, and F. Blasi An Uncleavable uPAR Mutant Allows Dissection of Signaling Pathways in uPA-dependent Cell Migration Mol. Biol. Cell, January 1, 2006; 17(1): 367 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhang, C. Chen, L. Li, L. Meng, J. Singh, N. Jiang, X.-W. Deng, Z.-H. He, and P. G. Lemaux Evolutionary Expansion, Gene Structure, and Expression of the Rice Wall-Associated Kinase Gene Family Plant Physiology, November 1, 2005; 139(3): 1107 - 1124. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Degryse, M. Resnati, R.-P. Czekay, D. J. Loskutoff, and F. Blasi Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity: GENERATION OF A NEW INTEGRIN INHIBITOR J. Biol. Chem., July 1, 2005; 280(26): 24792 - 24803. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pluskota, D. A. Soloviev, K. Bdeir, D. B. Cines, and E. F. Plow Integrin {alpha}M{beta}2 Orchestrates and Accelerates Plasminogen Activation and Fibrinolysis by Neutrophils J. Biol. Chem., April 23, 2004; 279(17): 18063 - 18072. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Verica, L. Chae, H. Tong, P. Ingmire, and Z.-H. He Tissue-Specific and Developmentally Regulated Expression of a Cluster of Tandemly Arrayed Cell Wall-Associated Kinase-Like Kinase Genes in Arabidopsis Plant Physiology, December 1, 2003; 133(4): 1732 - 1746. [Abstract] [Full Text] |
||||
![]() |
K. Bdeir, A. Kuo, B. S. Sachais, A. H. Rux, Y. Bdeir, A. Mazar, A. A.-R. Higazi, and D. B. Cines The kringle stabilizes urokinase binding to the urokinase receptor Blood, November 15, 2003; 102(10): 3600 - 3608. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. C. Shin and W. R. Folk Formation of Polyomavirus-Like Particles with Different VP1 Molecules That Bind the Urokinase Plasminogen Activator Receptor J. Virol., November 1, 2003; 77(21): 11491 - 11498. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G. McGuire, T. R. Jones, N. Talarico, E. Warren, and A. Das The Urokinase/Urokinase Receptor System in Retinal Neovascularization: Inhibition by A6 Suggests a New Therapeutic Target Invest. Ophthalmol. Vis. Sci., June 1, 2003; 44(6): 2736 - 2742. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. S. Kim, Y.-K. Hong, Y. A. Joe, Y. Lee, J.-Y. Shin, H.-E. Park, I.-H. Lee, S.-Y. Lee, D.-K. Kang, S.-I. Chang, et al. Anti-angiogenic Activity of the Recombinant Kringle Domain of Urokinase and Its Specific Entry into Endothelial Cells J. Biol. Chem., March 21, 2003; 278(13): 11449 - 11456. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pluskota, D. A. Soloviev, and E. F. Plow Convergence of the adhesive and fibrinolytic systems: recognition of urokinase by integrin alpha Mbeta 2 as well as by the urokinase receptor regulates cell adhesion and migration Blood, February 15, 2003; 101(4): 1582 - 1590. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Guo, A. P. Mazar, J.-J. Lebrun, and S. A. Rabbani An Antiangiogenic Urokinase-derived Peptide Combined with Tamoxifen Decreases Tumor Growth and Metastasis in a Syngeneic Model of Breast Cancer Cancer Res., August 15, 2002; 62(16): 4678 - 4684. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sidenius, A. Andolfo, R. Fesce, and F. Blasi Urokinase Regulates Vitronectin Binding by Controlling Urokinase Receptor Oligomerization J. Biol. Chem., July 26, 2002; 277(31): 27982 - 27990. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Vallera, C. Li, N. Jin, A. Panoskaltsis-Mortari, and W. A. Hall Targeting Urokinase-Type Plasminogen Activator Receptor on Human Glioblastoma Tumors With Diphtheria Toxin Fusion Protein DTAT J Natl Cancer Inst, April 17, 2002; 94(8): 597 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, L. Shao, S. Shi, R. J. Harris, M. W. Spellman, P. Stanley, and R. S. Haltiwanger Modification of Epidermal Growth Factor-like Repeats with O-Fucose. MOLECULAR CLONING AND EXPRESSION OF A NOVEL GDP-FUCOSE PROTEIN O-FUCOSYLTRANSFERASE J. Biol. Chem., October 19, 2001; 276(43): 40338 - 40345. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lally, P. Ingmire, H.-Y. Tong, and Z.-H. He Antisense Expression of a Cell Wall-Associated Protein Kinase, WAK4, Inhibits Cell Elongation and Alters Morphology PLANT CELL, June 1, 2001; 13(6): 1317 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Kjoller and A. Hall Rac Mediates Cytoskeletal Rearrangements and Increased Cell Motility Induced by Urokinase-type Plasminogen Activator Receptor Binding to Vitronectin J. Cell Biol., March 12, 2001; 152(6): 1145 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Bezerra, A. R. Currier, H. Melin-Aldana, G. Sabla, T. H. Bugge, K. W. Kombrinck, and J. L. Degen Plasminogen Activators Direct Reorganization of the Liver Lobule after Acute Injury Am. J. Pathol., March 1, 2001; 158(3): 921 - 929. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Klippel, E. Strunck, S. Roder, M. Lubbert, W. Lange, M. Azemar, G. Meinhardt, H.-E. Schaefer, and H. L. Pahl Cloning of PRV-1, a novel member of the uPAR receptor superfamily, which is overexpressed in polycythemia rubra vera Blood, April 15, 2000; 95(8): 2569 - 2576. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Moloney, L. H. Shair, F. M. Lu, J. Xia, R. Locke, K. L. Matta, and R. S. Haltiwanger Mammalian Notch1 Is Modified with Two Unusual Forms of O-Linked Glycosylation Found on Epidermal Growth Factor-like Modules J. Biol. Chem., March 24, 2000; 275(13): 9604 - 9611. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Webb, D. H. D. Nguyen, M. Sankovic, and S. L. Gonias The Very Low Density Lipoprotein Receptor Regulates Urokinase Receptor Catabolism and Breast Cancer Cell Motility in Vitro J. Biol. Chem., March 12, 1999; 274(11): 7412 - 7420. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sugiura, L. Ma, B. Sun, H. Shimada, W. E. Laug, R. C. Seeger, and Y. A. DeClerck The Plasminogen-Plasminogen Activator (PA) System in Neuroblastoma: Role of PA Inhibitor-1 in Metastasis Cancer Res., March 1, 1999; 59(6): 1327 - 1336. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ploug, H. Rahbek-Nielsen, P. F. Nielsen, P. Roepstorff, and K. Dano Glycosylation Profile of a Recombinant Urokinase-type Plasminogen Activator Receptor Expressed in Chinese Hamster Ovary Cells J. Biol. Chem., May 29, 1998; 273(22): 13933 - 13943. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. A. Quax, J. M. Grimbergen, M. Lansink, A. H. F. Bakker, M.-C. Blatter, D. Belin, V. W. M. van Hinsbergh, and J. H. Verheijen Binding of Human Urokinase-Type Plasminogen Activator to Its Receptor : Residues Involved in Species Specificity and Binding Arterioscler. Thromb. Vasc. Biol., May 1, 1998; 18(5): 693 - 701. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. D. Nguyen, I. M. Hussaini, and S. L. Gonias Binding of Urokinase-type Plasminogen Activator to Its Receptor in MCF-7 Cells Activates Extracellular Signal-regulated Kinase 1 and 2 Which Is Required for Increased Cellular Motility J. Biol. Chem., April 3, 1998; 273(14): 8502 - 8507. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Cirulli, L. Crisa, G.M. Beattie, M.I. Mally, A.D. Lopez, A. Fannon, A. Ptasznik, L. Inverardi, C. Ricordi, T. Deerinck, et al. KSA Antigen Ep-CAM Mediates Cell-Cell Adhesion of Pancreatic Epithelial Cells: Morphoregulatory Roles in Pancreatic Islet Development J. Cell Biol., March 23, 1998; 140(6): 1519 - 1534. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Plesner, N. Behrendt, and M. Ploug Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase-Type Plasminogen Activator Receptor, uPAR Stem Cells, November 1, 1997; 15(6): 398 - 408. [Abstract] [Full Text] |
||||
![]() |
L. M. Regan, J. S. Mollica, A. R. Rezaie, and C. T. Esmon The Interaction between the Endothelial Cell Protein C Receptor and Protein C Is Dictated by the gamma -Carboxyglutamic Acid Domain of Protein C J. Biol. Chem., October 17, 1997; 272(42): 26279 - 26284. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tran, W. J. VanDusen, and W. S. Argraves The Self-association and Fibronectin-binding Sites of Fibulin-1 Map to Calcium-binding Epidermal Growth Factor-like Domains J. Biol. Chem., September 5, 1997; 272(36): 22600 - 22606. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ciccocioppo, M. G. Capri, and S. Alberti Detection of the Receptor for the Human Urokinase-type Plasminogen Activator Using Fluoresceinated uPA J. Histochem. Cytochem., September 1, 1997; 45(9): 1307 - 1314. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ginestra, S. Monea, G. Seghezzi, V. Dolo, H. Nagase, P. Mignatti, and M. L. Vittorelli Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells J. Biol. Chem., July 4, 1997; 272(27): 17216 - 17222. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Li, E. G. Karakji, R. Xing, J. N. Fryer, J. A. Carnegie, S. A. Rabbani, and B. K. Tsang Expression of Urokinase-Type Plasminogen Activator and Its Receptor during Ovarian Follicular Development Endocrinology, July 1, 1997; 138(7): 2790 - 2799. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Franco, C. Iaccarino, F. Chiaradonna, A. Brandazza, C. Iavarone, M. R. Mastronicola, M. L. Nolli, and M. P. Stoppelli Phosphorylation of Human Pro-Urokinase on Ser138/303 Impairs Its Receptor-dependent Ability to Promote Myelomonocytic Adherence and Motility J. Cell Biol., May 5, 1997; 137(3): 779 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ambrosini, J. Plescia, K. C. Chu, K. A. High, and D. C. Altieri Activation-dependent Exposure of the Inter-EGF Sequence Leu83-Leu88 in Factor Xa Mediates Ligand Binding to Effector Cell Protease Receptor-1 J. Biol. Chem., March 28, 1997; 272(13): 8340 - 8345. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A.-R. Higazi, A. Mazar, J. Wang, N. Quan, R. Griffin, R. Reilly, J. Henkin, and D. B. Cines Soluble Human Urokinase Receptor Is Composed of Two Active Units J. Biol. Chem., February 21, 1997; 272(8): 5348 - 5353. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Bonavaud, C Charriere-Bertrand, C Rey, M. Leibovitch, N Pedersen, E Frisdal, E Planus, F Blasi, R Gherardi, and G Barlovatz-Meimon Evidence of a non-conventional role for the urokinase tripartite complex (uPAR/uPA/PAI-1) in myogenic cell fusion J. Cell Sci., January 5, 1997; 110(9): 1083 - 1089. [Abstract] [PDF] |
||||
![]() |
C. Rogers, F. G.P. Welt, M. J. Karnovsky, and E. R. Edelman Monocyte Recruitment and Neointimal Hyperplasia in Rabbits: Coupled Inhibitory Effects of Heparin Arterioscler. Thromb. Vasc. Biol., October 1, 1996; 16(10): 1312 - 1318. [Abstract] [Full Text] |
||||
![]() |
N. Behrendt, E. Ronne, and K. Dano Domain Interplay in the Urokinase Receptor. REQUIREMENT FOR THE THIRD DOMAIN IN HIGH AFFINITY LIGAND BINDING AND DEMONSTRATION OF LIGAND CONTACT SITES IN DISTINCT RECEPTOR DOMAINS J. Biol. Chem., September 13, 1996; 271(37): 22885 - 22894. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Bugge, T. T. Suh, M. J. Flick, C. C. Daugherty, J. R, H. Solberg, V. Ellis, K. Danø, and J. L. Degen The Receptor for Urokinase-type Plasminogen Activator Is Not Essential for Mouse Development or Fertility J. Biol. Chem., July 14, 1995; 270(28): 16886 - 16894. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-I W. Q. Y. and Charles S. Craik and C. I. Wang Isolation of a High Affinity Inhibitor of Urokinase-type Plasminogen Activator by Phage Display of Ecotin J. Biol. Chem., May 19, 1995; 270(20): 12250 - 12256. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Mandriota, G. Seghezzi, J.-D. Vassalli, N. Ferrara, S. Wasi, R. Mazzieri, P. Mignatti, and M. S. Pepper Vascular Endothelial Growth Factor Increases Urokinase Receptor Expression in Vascular Endothelial Cells J. Biol. Chem., April 28, 1995; 270(17): 9709 - 9716. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Novokhatny, L. Medved, H. R. Lijnen, and K. Ingham Tissue-type Plasminogen Activator (tPA) Interacts with Urokinase-type Plasminogen Activator (uPA) via tPA's Lysine Binding Site J. Biol. Chem., April 14, 1995; 270(15): 8680 - 8685. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Naldini, E. Vigna, A. Bardelli, A. Follenzi, F. Galimi, and P. M. Comoglio Biological Activation of pro-HGF (Hepatocyte Growth Factor) by Urokinase Is Controlled by a Stoichiometric Reaction J. Biol. Chem., January 13, 1995; 270(2): 603 - 611. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. McGuire and S. Alexander Inhibition of urokinase synthesis and cell surface binding alters the motile behavior of embryonic endocardial-derived mesenchymal cells in vitro Development, January 7, 1993; 118(3): 931 - 939. [Abstract] [PDF] |
||||
![]() |
F. Del Amo, D. Smith, P. Swiatek, M Gendron-Maguire, R. Greenspan, A. McMahon, and T Gridley Expression pattern of Motch, a mouse homolog of Drosophila Notch, suggests an important role in early postimplantation mouse development Development, January 7, 1992; 115(3): 737 - 744. [Abstract] [PDF] |
||||
![]() |
O. D. Liang, T. Chavakis, S. M. Kanse, and K. T. Preissner Ligand Binding Regions in the Receptor for Urokinase-type Plasminogen Activator. STRUCTURAL REQUIREMENTS FOR A MULTIDOMAIN BINDING REGION AND RECEPTOR-RECEPTOR INTERACTION J. Biol. Chem., July 27, 2001; 276(31): 28946 - 28953. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mukhina, V. Stepanova, D. Traktouev, A. Poliakov, R. Beabealashvilly, Y. Gursky, M. Minashkin, A. Shevelev, and V. Tkachuk The Chemotactic Action of Urokinase on Smooth Muscle Cells Is Dependent on Its Kringle Domain. CHARACTERIZATION OF INTERACTIONS AND CONTRIBUTION TO CHEMOTAXIS J. Biol. Chem., May 26, 2000; 275(22): 16450 - 16458. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |